Kovai Medical Center Hospital Ltd vs Transgene Biotek Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Kovai Medical Center & Hospital Ltd is ₹ 5737 as of 23 Oct 15:30 . The P/E Ratio of Kovai Medical Center & Hospital Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Transgene Biotek Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Kovai Medical Center & Hospital Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Transgene Biotek Ltd changed from ₹ 34.7 crore on March 2021 to ₹ 25.38 crore on March 2025 . This represents a CAGR of -6.06% over 5 years The revenue of Kovai Medical Center & Hospital Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Transgene Biotek Ltd for the Jun '26 is ₹ 0.06 crore as compare to the Mar '26 revenue of ₹ 0.2 crore. This represent the decline of -70% The ebitda of Kovai Medical Center & Hospital Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Transgene Biotek Ltd for the Jun '26 is ₹ -0.06 crore as compare to the Mar '26 ebitda of ₹ -0.13 crore. This represent the decline of -53.85% The net profit of Kovai Medical Center & Hospital Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Transgene Biotek Ltd changed from ₹ 0.2 crore to ₹ -0.39 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Kovai Medical Center & Hospital Ltd changed from 4.22 % on March 2021 to 6.71 % on March 2026 . This represents a CAGR of 8.04% over 6 yearsThe Dividend Payout of Transgene Biotek Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Kovai Medical Center & Hospital Ltd

Kovai Medical Center and Hospital Limited was incorporated as a Public Company in year 1985 and commenced its hospital operation in year 1990 with the flagship of Multi-Speciality Hospital at Coimbatore with a capacity of 200 Bed Hospital.
Thereafter, the Hospital set up the satellite centers at Coimbatore in the name of City Center, Sulur Hospital and Kovilpalayam Hospital and Erode in the name of Erode Speciality Hospital. Today, KMCH has grown into a 2,250 bed multi-locational, multi-disciplinary Super specialty hospital, the best and most trusted in Southern India.
The Hospital is equipped with most modern equipments like CT Scanner, Angiograpy equipment with DSA, Operating Microscope, Mammography, C-arm, Color Doppler etc.
There are over 30 Medical Departments and 11 Operation Theatres at the Hospital.

About Transgene Biotek Ltd

Founded in March 1990 by Dr. Koteswara Rao, Transgene Biotek Limited was one of the first Biotechnology companies in India.
Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc.
The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.

FAQs for the comparison of Kovai Medical Center & Hospital Ltd and Transgene Biotek Ltd

Which company has a larger market capitalization, Kovai Medical Center & Hospital Ltd or Transgene Biotek Ltd?

Market cap of Kovai Medical Center & Hospital Ltd is 6,277 Cr while Market cap of Transgene Biotek Ltd is 19 Cr

What are the key factors driving the stock performance of Kovai Medical Center & Hospital Ltd and Transgene Biotek Ltd?

The stock performance of Kovai Medical Center & Hospital Ltd and Transgene Biotek Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Kovai Medical Center & Hospital Ltd and Transgene Biotek Ltd?

As of October 25, 2026, the Kovai Medical Center & Hospital Ltd stock price is INR ₹5737.95. On the other hand, Transgene Biotek Ltd stock price is INR ₹2.57.

How do dividend payouts of Kovai Medical Center & Hospital Ltd and Transgene Biotek Ltd compare?

To compare the dividend payouts of Kovai Medical Center & Hospital Ltd and Transgene Biotek Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.